By DAMIAN WONJO
Each doctor maintains a private list of patients he or she does not see. Not those who cancel, those who never book. The shift worker who reschedules the same appointment three times and then quietly gives up. The parent who can’t justify a half day off and an afternoon in the waiting room for a routine recharge. The patient whose condition carries enough stigma that the friction of a face-to-face visit becomes, in itself, a reason to do nothing. These people do not appear in the no-show statistics. They appear later, as complications, as emergencies, as avoidable deterioration.
This is the access gap, and from my point of view as a doctor in Europe, it has less to do with the raw supply of doctors than with the cost of reaching one, measured not only in money but also in time, distance and effort. When that cost exceeds the patient’s tolerance, care simply is not provided. Online prescription services and remote consultations will not solve all aspects of this problem. But they point precisely to the variable that most reforms ignore: friction.
Patients who fail
It’s tempting to frame telemedicine as a convenience for those who are already healthy and connected. In practice, the people who benefit the most tend to be those who have the least slack in their lives. A patient stabilized on the same antihypertensive drug for three years does not need a new diagnostic odyssey to continue it, he needs a prescription before it runs out. A working adult who recognizes a recurring family problem does not always need a physical exam to safely receive help. Forcing each such encounter through the narrow door of an in-person date doesn’t raise the level of attention, but rather increases the rate at which people abandon it.
Continuity is what matters most. Chronic conditions are managed through refills, and a missed refill is not an administrative event but rather an interruption in treatment with real physiological consequences. Lowering the barrier to that recharge is not a luxury. It is quietly one of the highest performing interventions available.
What changed in Europe?
The pandemic did not invent telemedicine, but it normalized it and accelerated the underlying infrastructure. Poland is a useful case study. Electronic prescriptions became the national standard in 2020, and today virtually all prescriptions are issued digitally, can be retrieved by the patient through a government health account, and dispensed at any pharmacy with a code. The clinical encounter and prescription were dissociated from a single physical location without being dissociated from an authorized prescriber.
That distinction is the entire argument. A responsible online prescription service is not a vending machine. He is a licensed doctor, who works within the same legal and ethical framework as any clinic, using a different channel to reach the patient. Technology is mundane. The consequence is that a patient who otherwise would have gone without is now not cared for.
honest limits
I want to be precise about where this model should not go, because credibility depends on it. Remote prescribing is appropriate for continuation of stable therapy, for clearly defined, low-risk presentations, and for situations in which a careful history is essentially sufficient. It is not appropriate as a substitute for examination when there are warning symptoms, for increasing or undifferentiated complaints, for most controlled substances, or when the absence of a physical examination significantly increases risk. A good service incorporates these limits into its classification and refers patients when the safe answer is that they need to be seen in person.
Telemedicine that ignores these limits does not close the access gap, but rather relocates the risk. Doctors and platforms that do it well are the most willing to steer patients away from the online channel when that is the right decision. Comfort is the feature. Clinical judgment is still the product.
What the conversation often overlooks
Debates about online prescribing tend to fall into a binary: either it’s about dangerous shortcuts or it’s about frictionless progress. Neither frame is useful. The more honest question is more limited. For which patients and which problems does removing the friction of an in-person visit improve outcomes without degrading safety? For a large, underserved middle segment—that is, stable chronic patients, predictable refills, and conditions that people are reluctant to present in person—the answer is becoming clearer. For acute, complex or high-risk care, it is still no.
Health systems on both sides of the Atlantic spend enormous amounts of energy expanding their capacity and almost none on reducing the friction that wastes it. A patient who never books is invisible to a system optimized around patients who do. Online prescription services, used within appropriate limits, make some of those invisible patients visible again. That is not a revolution. It is something more lasting, a silent correction of a gap we had simply stopped noticing.
Dr. Damian Wojno is a doctor who collaborates with the Polish telemedicine service. eReceive online24.
